We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+9.75%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$268B
AUM Growth
+$39.7B
Cap. Flow
+$21.8B
Cap. Flow %
8.14%
Top 10 Hldgs %
12.83%
Holding
12,049
New
1,180
Increased
5,215
Reduced
3,564
Closed
1,371

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$850M
2
AAPL icon
Apple
AAPL
+$778M
3
TSLA icon
Tesla
TSLA
+$569M
4
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$351M
5
JNJ icon
Johnson & Johnson
JNJ
+$336M

Sector Composition

Rank Sector Weight
1 Technology 10.83%
2 Healthcare 7.49%
3 Financials 7.15%
4 Consumer Discretionary 4.92%
5 Industrials 4.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FAZE
10576
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
$2 ﹤0.01%
1
SUAC.WS
10577
DELISTED
ShoulderUp Technology Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
SUAC.WS
$2 ﹤0.01%
100
-4,563
-98% -$137
BIOSW
10578
DELISTED
BioPlus Acquisition Corp. Warrants
BIOSW
$2 ﹤0.01%
215
+115
+115% +$6
HMA.WS
10579
DELISTED
Heartland Media Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
HMA.WS
$2 ﹤0.01%
+50
New +$3
DOMA.WS
10580
DELISTED
Doma Holdings, Inc. Warrants, Every 25 warrants will be exercisable for one share of Common Stock at an exercise price of $287.50 per share of Common Stock
DOMA.WS
$2 ﹤0.01%
+76
New +$2
TMQ
10581
Trilogy Metals
TMQ
$541M
$1 ﹤0.01%
2
-33
-94% -$19
NIXX
10582
Nixxy Inc
NIXX
$15.4M
0
BNIXW
10583
DELISTED
Bannix Acquisition Corp. Warrant
BNIXW
$1 ﹤0.01%
100
-20,167
-100% -$480
FTIIW
10584
DELISTED
FutureTech II Acquisition Corp. Warrant
FTIIW
$1 ﹤0.01%
+100
New +$2
BLEUR
10585
DELISTED
bleuacacia ltd Rights
BLEUR
$1 ﹤0.01%
+20
New +$2
DPCSW
10586
DELISTED
DP Cap Acquisition Corp I Warrants
DPCSW
$1 ﹤0.01%
+100
New +$5
PLAOW
10587
DELISTED
Patria Latin American Opportunity Acquisition Corp. Warrant
PLAOW
$1 ﹤0.01%
9
-199
-96% -$14
ASCAW
10588
DELISTED
A SPAC I Acquisition Corp. Warrant
ASCAW
$1 ﹤0.01%
+100
New +$2
HPLTW
10589
DELISTED
Home Plate Acquisition Corporation Warrant
HPLTW
$1 ﹤0.01%
50
-180
-78% -$5
GRNAW
10590
DELISTED
GreenLight Biosciences Holdings, PBC Warrant
GRNAW
$1 ﹤0.01%
+13
New +$2
SCAQW
10591
DELISTED
Stratim Cloud Acquisition Corp. Warrant
SCAQW
$1 ﹤0.01%
51
-11,193
-100% -$377
APTO
10592
DELISTED
Aptose Biosciences, Inc.
APTO
0
AGRX
10593
DELISTED
Agile Therapeutics
AGRX
-1,103
Closed -$12.8K
XELA
10594
DELISTED
Exela Technologies, Inc. Common Stock
XELA
0
AACG
10595
ATA Creativity
AACG
$39.3M
-1,465
Closed -$3K
AAPB icon
10596
GraniteShares 2x Long AAPL Daily ETF
AAPB
$16.6M
-1,689
Closed -$30K
ABOS icon
10597
Acumen Pharmaceuticals
ABOS
$155M
-2,687
Closed -$27K
ABR icon
10598
PUT
Arbor Realty Trust
ABR
$964M
-272,800
Closed -$3.14M
ACSI icon
10599
American Customer Satisfaction ETF
ACSI
$116M
-548
Closed -$23K
ACWI icon
10600
CALL
iShares MSCI ACWI ETF
ACWI
$32.5B
-3,500,000
Closed -$272M

Similar funds

UBS Group's Q4 2022 Portfolio in Review

As of Q4 2022, UBS Group held 12,049 positions worth $268B, up 17% from $228B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group deployed $21.8B of net new capital in Q4 2022, opening 1,180 new positions and adding to 5,215 existing holdings. Its largest new stake was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Salesforce, an estimated $372M trimmed.

  • UBS Group's largest Q4 2022 buy was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.
  • UBS Group added most to Microsoft in Q4 2022, an estimated $850M increase.
  • UBS Group's biggest Q4 2022 reduction was Salesforce, cutting an estimated $372M.
  • UBS Group fully exited Citrix Systems Inc in Q4 2022, selling an estimated $223M.
  • UBS Group's ten largest holdings make up 13% of its $268B portfolio in Q4 2022.
  • UBS Group opened 1,180 new positions and closed 1,371 in Q4 2022.
  • UBS Group's portfolio value rose 17% quarter-over-quarter to $268B.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.